Salix Pharma (SLXP): Q2 EPS of $0.32 misses by $0.12. Revenue of $133.1M (+43% Y/Y) beats by $2M. Reaffirms FY11 Revenue guidance of $520M and PAT of $110M (excl. payments to Lupin). Shares +0.5% AH. (PR)
Are you Bullish or Bearish on ?
Results for ()
Thanks for sharing your thoughts.
From other sites
at Nasdaq.com (Wed, 4:39PM)
at Investor's Business Daily (Feb 23, 2015)
at Benzinga.com (Feb 23, 2015)
at Investor's Business Daily (Feb 20, 2015)
at Investor's Business Daily (Feb 13, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs